References: Clozapine for treatment-resistant schizophrenia in adults and young people

  • Alawami M, Wasywich C, Cicovic A, Kenedi C. A systematic review of clozapine induced cardiomyopathy. Int J Cardiol 2014;176(2):315–20. https://www.ncbi.nlm.nih.gov/pubmed/25131906
  • Chen SY, Ravindran G, Zhang Q, Kisely S, Siskind D. Treatment strategies for clozapine-induced sialorrhea: A systematic review and meta-analysis. CNS Drugs 2019;33(3):225–38. https://www.ncbi.nlm.nih.gov/pubmed/30758782
  • Clark SR, Warren NS, Kim G, Jankowiak D, Schubert KO, Kisely S, et al. Elevated clozapine levels associated with infection: A systematic review. Schizophr Res 2018;192:50–6. https://www.ncbi.nlm.nih.gov/pubmed/28392207
  • Cohen D, Bogers JP, van Dijk D, Bakker B, Schulte PF. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. J Clin Psychiatry 2012;73(10):1307–12. https://www.ncbi.nlm.nih.gov/pubmed/23140648
  • Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry 2016;50(5):410–72. https://www.ncbi.nlm.nih.gov/pubmed/27106681
  • Masuda T, Misawa F, Takase M, Kane JM, Correll CU. Association with hospitalization and all-cause discontinuation among patients with schizophrenia on clozapine vs other oral second-generation antipsychotics: A systematic review and meta-analysis of cohort studies. JAMA Psychiatry 2019;76(10):1052–62. https://www.ncbi.nlm.nih.gov/pubmed/31365048
  • Ronaldson KJ, Fitzgerald PB, McNeil JJ. Clozapine-induced myocarditis, a widely overlooked adverse reaction. Acta Psychiatr Scand 2015;132(4):231–40. https://www.ncbi.nlm.nih.gov/pubmed/25865238
  • Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry 2011;45(6):458–65. https://pubmed.ncbi.nlm.nih.gov/21524186/
  • Segev A, Evans A, Hodsoll J, Whiskey E, Sheriff RS, Shergill S, et al. Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial. Int Clin Psychopharmacol 2019;34(2):101–7. https://www.ncbi.nlm.nih.gov/pubmed/30614850
  • Siskind D, McCartney L, Goldschlager R, Kisely S. Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2016;209(5):385–92. https://www.ncbi.nlm.nih.gov/pubmed/27388573
  • Stark A, Scott J. A review of the use of clozapine levels to guide treatment and determine cause of death. Aust N Z J Psychiatry 2012;46(9):816–25. https://pubmed.ncbi.nlm.nih.gov/22327098/